Rob English (self massage guru) now sells his own drug? Update 4/7/2026
Rob English, known for promoting scalp massages for hair regrowth, now sells his own brand of finasteride and minoxidil. Opinions are mixed, with some calling him a charlatan and others acknowledging his shift towards scientifically-backed treatments.
View this post in the Community →
Similar Community Posts Join
6 / 6 resultscommunity I can’t tell if it’s regrowth or not but this is my result after 9 months on fin
The user has been using finasteride daily, scalp massages, micro-needling, and Nizoral shampoo for hair loss, with noticeable progress after 9 months. They are considering adding minoxidil but are hesitant due to concerns about long-term commitment.
community Why is minoxidil the “regrowth stimulant” and finasteride “the maintenance”, when official studies show more growth on finasteride ?
Finasteride is more effective for long-term hair maintenance by addressing the root cause of hair loss, while minoxidil acts as a growth stimulant with faster visible results. Combining both treatments is optimal, with oral minoxidil often showing better results for some individuals.
community 2.5 years Minoxidil and HRT, CPA->Lupron +Minox 5%
The user experienced significant hair regrowth after 2.5 years of using Minoxidil 5% and hormone replacement therapy (HRT) with Lupron, despite initial scalp irritation. Finasteride was ineffective for them.
community 2 months of finasteride and 3 months of minoxidil
The user experienced hair regrowth and thickening after using minoxidil for three months and finasteride for two months, along with vitamin D and iron supplements. They reported softer erections as a side effect of finasteride but found the hair improvements worth it.
community My progress with finasteride and minoxidil.
A 26-year-old male experienced significant hair regrowth using finasteride and minoxidil, with no side effects, and is considering switching to dutasteride. He applies minoxidil topically and takes finasteride daily, noting the importance of consistent lighting for progress photos.
community No regrowth after oral min, topical fin, min, and tret: Aggressive diffuse/hairline recession in 2 years
A user experienced no hair regrowth after using oral minoxidil, topical finasteride, minoxidil, and tretinoin, and reported side effects from oral finasteride. They are considering switching to dutasteride or using hair fibers for better results.
Related Research
6 / 6 resultsresearch Self-Assessments of Standardized Scalp Massages for Androgenic Alopecia: Survey Results
This study found that standardized scalp massages may help stabilize or regrow hair in individuals with androgenic alopecia, as perceived by the participants themselves.
research Real-time in vivo structure-function study of scalp hair cycles: an experimental approach for monitoring living hair roots with a 20-year follow-up
In this study, after long-term observation of human scalp hair follicles over 16 years, the researchers found that a topical 5% minoxidil solution could stimulate hair regrowth after a period of dormancy, though with reduced growth rates and hair diameter.
research Hair regrowth with novel hemp extract: A case series
In a case series, this study reported significant hair regrowth in both men and women with androgenetic alopecia using a topical hemp extract high in CBD, THCV, and CBDV over six months.
research Scalp threading – new treatment option for Androgenetic Alopecia
This review discusses Scalp Threading as a promising treatment for androgenic alopecia, with hair growth results comparable to multiple applications of minoxidil, but reports no new clinical results.
research Oral Presentations
This article discusses various aspects of hair and scalp health, ancient philosophical perspectives on hair, and causes of hair disorders in children, without reporting new clinical results.
research Male pattern hair loss: prevention rather than regrowth
This article discusses the importance of focusing on prevention rather than regrowth in managing male pattern hair loss but reports no new clinical results.